2000
DOI: 10.1016/s0010-7824(00)00113-x
|View full text |Cite
|
Sign up to set email alerts
|

Progesterone release from glutaraldehyde cross-linked casein microspheres: In vitro studies and in vivo response in rabbits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
49
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(49 citation statements)
references
References 17 publications
0
49
0
Order By: Relevance
“…In a previous work, ascorbyl palmitate was more easily released from TPP-crosslinked chitosan nanoparticles at low TPP concentration because of the low-density structure. 36 Previous studies showed a sustained-release ability of drugs (eg, mitoxantrone 37 and progesterone 38 ) from glutaraldehyde-crosslinked CAS microparticles, where the rate of drug release was found to decrease with the increase in the glutaraldehyde concentration.…”
Section: In Vitro Release Of Flt From Cas Nanoparticlesmentioning
confidence: 99%
“…In a previous work, ascorbyl palmitate was more easily released from TPP-crosslinked chitosan nanoparticles at low TPP concentration because of the low-density structure. 36 Previous studies showed a sustained-release ability of drugs (eg, mitoxantrone 37 and progesterone 38 ) from glutaraldehyde-crosslinked CAS microparticles, where the rate of drug release was found to decrease with the increase in the glutaraldehyde concentration.…”
Section: In Vitro Release Of Flt From Cas Nanoparticlesmentioning
confidence: 99%
“…Biopolymer micro and nanoparticles have been proposed as an alternative to encapsulate progesterone (JAMEELA et al, 1998;LEMOS-SENNA et al, 1998;MATSUMOTO et al, 1999;LATHA et al, 2000;SILVA et al, 2006;SALEM, 2010). It is worth noting that besides the controlled delivery, encapsulation also provides protection from premature degradation during handling and storage before use, enhancement of absorption and bioavailability, improved retention time inside the organism and improvement of intracellular penetration (KUMARI et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…24 In the case of casein, microspheres cross-linked with glutaraldehyde have been used for progesterone release . 20 In this study, our particular interest was to analyze the permeation rate of p-hydroxyacetanilide (a model drug) through gelatin/caseins films cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC). The permeation behavior was evaluated considering the thermal, mechanical, morphologic, and water absorption properties of the cross-linked system.…”
Section: Introductionmentioning
confidence: 99%
“…18 In general, p-hydroxyacetanilide is effective with ingested doses ranging between 0.5 -1.0 g every 3 or 4 h. Considering that this causes inconvenience to the patient, many polymeric systems have been tested as new ways to control the release of different drugs. [19][20][21][22][23][24] Investigations have been carried out in order to obtain an ideal model for drug delivery with high specificity and activity without toxic effects. 25 Along with several drug delivery systems using membrane-controlled diffusion, films and membranes for transdermal delivery have also been studied.…”
mentioning
confidence: 99%